OCGN.MX Ocugen, Inc.
Company Analysis
Latest News
🟢 Ocugen is trading 5.7% up today with prior-session Q3 results potentially supporting gains
Ocugen is trading at MXN 16.91, up 5.69%, with its prior-session Q3 results potentially supporting the gain. - Its November 4 report showed $1.95 million in...
🟢 Ocugen is trading 6.2% up after strong Q3 earnings beat and positive business update
Ocugen reported better-than-expected third-quarter results and provided a positive business update: Revenue of $1.95 million** surpassed consensus estimates...
🔴 Ocugen is trading 6.6% down with no clear company-specific catalyst identified
Ocugen is trading at MXN 14.01, down 6.60%, with no clear company-specific catalyst identified in available coverage. - U.S. markets were lower, including the...
🟢 Ocugen is trading 7.14% up today amid biotech-sector gains
Ocugen is trading at MXN 15.00, up +7.14%, amid a supportive biotech backdrop, though no direct cause is established. - No confirmed company-specific...
🔴 Ocugen is trading 5% down today with the cause still unclear
Ocugen is trading 5.00% down at MXN 15.20 on October 16, 2026, with the cause unclear. - No company-specific announcement directly explains the decline. Recent...
🔴 Ocugen is trading 5% down today amid renewed U.S. inflation and rate concerns
Ocugen is trading 5.00% down at MXN 15.20, with broader risk-off pressure amid hotter-than-expected U.S. producer-price inflation the likeliest context, though...
🔴 Ocugen is trading 5.88% down amid biotech and market pressure
Ocugen is trading at MXN 16.00, down 5.88%; macro and sector weakness are the likeliest context, with no confirmed company-specific catalyst. -...
🔴 Ocugen is trading 11% down
Ocugen is trading at MXN 16.96, down 10.74%, with no confirmed company-specific announcement explaining the October 12 decline. - Provided market context...
🔴 Ocugen is trading 11% down today; no confirmed company-specific catalyst
Ocugen is trading at MXN 16.96, with a change of -10.74% on October 9, 2026; no confirmed company-specific news directly explains the decline. - Ocugen is...
Ocugen's 8% Rally on Data Day: Can a Pre-Revenue Gene Therapy Firm Justify the Hype Before Results Hit the Podium
Shares of Ocugen jumped 8% to MXN 18.44 ahead of two clinical presentations scheduled today at The Retina Society's 59th Annual Scientific Meeting in Los...
🟢 Ocugen is trading 8% up today ahead of September 24 OCU410ST and OCU410 presentations
Ocugen is trading 8.03% up at MXN 18.44 as investors anticipate clinical presentations scheduled for September 24, 2026, at The Retina Society. - The company...
🟢 Ocugen is trading 7.97% up today ahead of OCU410ST Phase 1 data presentation
Ocugen is trading 7.97% higher at MXN 18.43, as its scheduled OCU410ST Phase 1 data presentation may be drawing attention. - Ocugen is scheduled to present...
🔴 Ocugen is trading 16.67% down today with immediate cause unclear
Ocugen is trading at MXN 20.00, down 16.67%, with the immediate cause unclear. - The scheduled Citi 2026 Biopharma Back to School Conference presentation is...
🔴 Ocugen is trading 8.33% down today with no clear company-specific catalyst
Ocugen is trading 8.33% down at MXN 22.00, with no clear company-specific catalyst reported for September 9, 2026. - Ocugen is scheduled to present at the...